Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Institutional Investors Approve of SEC’s Shareholder Proxy Changes
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Whoops! No proof indeed. Misread Fut's post to mean they had. Just checked the filing and see that's not the case. Thanks for the fact check.

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply